Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female
Interventions: DRUG: oral microencapsulated diindolylmethane|OTHER: laboratory biomarker analysis
Sponsor: Barbara Ann Karmanos Cancer Institute
Collaborators: National Cancer Institute (NCI)